Historically, medical therapy for ulcerative colitis (UC) was limited to corticosteroids. Excitingly, over the past just 1–2 decades, the options for medical therapy have expanded and include biologics and small molecules, with more agents actively being developed. In this article, we review the current and emerging treatment strategies for UC stratified according to disease severity. Keywords: ulcerative colitis; biologic; small molecule; colectom
Introduction: Anti TNF-α agents have become a significant advance in the management of ulcerative co...
Introduction: Up to one-third of patients with ulcerative colitis (UC) do not respond to standard me...
Ulcerative colitis (UC) is the most prevalent inflamma-tory bowel disease, and its global incidence ...
Ulcerative colitis (UC) is a disease of unknown etiology characterized by inflammation of the mucosa...
Background: Ulcerative colitis (UC) is a chronic, relapsing inflammatory disorder of the colon for w...
Ulcerative colitis (UC) is an idiopathic chronic inflammatory disease of the colonic mucosa. Over th...
Introduction: Ulcerative colitis (UC) by definition is an inflammation of the mucosa of the colon, i...
As biologic-based medication options for ulcerative colitis expand, our understanding of their optim...
The treatment of ulcerative colitis (UC) has changed over the last decade. It is extremely important...
Introduction: Treatment of ulcerative colitis (UC) is constantly evolving. In the last two decades, ...
Ulcerative colitis (UC) is a major form of inflammatory bowel disease (IBD) worldwide. Better unders...
The incidence and prevalence of ulcerative colitis are increasing globally. Although the exact cause...
Ulcerative colitis, one of the two main forms of inflammatory bowel disease, is characterized by inf...
The approved treatment options for patients with ulcerative colitis (UC) are currently limited to me...
The care for a patient with moderate to severe ulcerative colitis remains challenging in spite of th...
Introduction: Anti TNF-α agents have become a significant advance in the management of ulcerative co...
Introduction: Up to one-third of patients with ulcerative colitis (UC) do not respond to standard me...
Ulcerative colitis (UC) is the most prevalent inflamma-tory bowel disease, and its global incidence ...
Ulcerative colitis (UC) is a disease of unknown etiology characterized by inflammation of the mucosa...
Background: Ulcerative colitis (UC) is a chronic, relapsing inflammatory disorder of the colon for w...
Ulcerative colitis (UC) is an idiopathic chronic inflammatory disease of the colonic mucosa. Over th...
Introduction: Ulcerative colitis (UC) by definition is an inflammation of the mucosa of the colon, i...
As biologic-based medication options for ulcerative colitis expand, our understanding of their optim...
The treatment of ulcerative colitis (UC) has changed over the last decade. It is extremely important...
Introduction: Treatment of ulcerative colitis (UC) is constantly evolving. In the last two decades, ...
Ulcerative colitis (UC) is a major form of inflammatory bowel disease (IBD) worldwide. Better unders...
The incidence and prevalence of ulcerative colitis are increasing globally. Although the exact cause...
Ulcerative colitis, one of the two main forms of inflammatory bowel disease, is characterized by inf...
The approved treatment options for patients with ulcerative colitis (UC) are currently limited to me...
The care for a patient with moderate to severe ulcerative colitis remains challenging in spite of th...
Introduction: Anti TNF-α agents have become a significant advance in the management of ulcerative co...
Introduction: Up to one-third of patients with ulcerative colitis (UC) do not respond to standard me...
Ulcerative colitis (UC) is the most prevalent inflamma-tory bowel disease, and its global incidence ...